The primary-progressive (PP) form represents 10% -15% of the overall multiple sclerosis (MS) patient population, -45,000 in the US. Compared with the more prevalent (~80%) relapsing-remitting (RR) form of the disease, PP-MS is characterized by a discrepancy between the severity of clinical deterioration and the paucity of MRI indicators: Fewer lesions, lower lesion formation rate, and less contrast enhancement. The insensitivity of the radiological markers has precluded PP-MS patients from most randomized trials of new treatments, in which efficacy is evaluated by both clinical outcomes and MRI metrics (number of enhancing and new T2 lesions). Consequently, no treatments are currently offered, even though the prognosis for this phenotype is worse than for RR-MS. It has been suggested that the disparity between clinical and MR findings might be due to MRI-occult brain pathology. Therefore, our central premise is that such diffuse microscopic damage must play a key role in disease progression, leading us to formulate three hypotheses: ? ? Hypothesis 1 (HI): Ongoing axonal damage, reflected by whole-brain ./V-acetylaspartate (WBNAA) deficit, will be greater in PP-MS than in RR-MS and will correlate with poorer cognitive performance. Hypothesis 2 (H2): Choline (Cho) and creatine (Cr) levels will be lower in PP-MS than in RR-MS patients, reflecting less inflammation and oligodendrocyte apoptosis; finally, wyo-inositol (ml) levels will be higher due to increased gliosis; Hypothesis 3 (H3): perfusion-MRI metrics (cerebral blood flow and mean transit time) will be more impaired in PP-MS than in RR-MS patients, due to less intense but more prolonged inflammation. The perfusion metrics will be correlated with cerebrospinal fluid (CSF) and blood levels of tumor necrosis factor-a (TNF-a) which is related to ischemic injury and neurodegeneration. To test these hypotheses we propose three Specific Aims:
Specific Aim 1 : To compare the WBNAA, Cho, Cr and ml levels in PP-MS, age and sex matched RR-MS and healthy control subjects.
Specific Aim 2 : To compare the perfusion MRI metrics in the same three subject groups.
Specific Aim 3 : To correlate WBNAA and perfusion-MRI metrics against each other and with clinical measures of neurological and cognitive impairment, CSF and blood levels of TNF- and its soluble receptors. The health relatedness of this project: (i) To test quantitative MRI and 'H-MRS potential surrogate markers of disease activity that could facilitate effective monitoring of PP-MS in clinical trials, (ii) To investigate the relationship between microvascular changes, demyelination and neurodegeneration in MS. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
1R01NS051623-01A1
Application #
7039294
Study Section
Medical Imaging Study Section (MEDI)
Program Officer
Utz, Ursula
Project Start
2006-01-01
Project End
2009-12-31
Budget Start
2006-01-01
Budget End
2006-12-31
Support Year
1
Fiscal Year
2006
Total Cost
$380,250
Indirect Cost
Name
New York University
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016
Grossman, Elan J; Inglese, Matilde (2016) The Role of Thalamic Damage in Mild Traumatic Brain Injury. J Neurotrauma 33:163-7
Grossman, Elan J; Kirov, Ivan I; Gonen, Oded et al. (2015) N-acetyl-aspartate levels correlate with intra-axonal compartment parameters from diffusion MRI. Neuroimage 118:334-43
Fleysher, Lazar; Oesingmann, Niels; Brown, Ryan et al. (2013) Noninvasive quantification of intracellular sodium in human brain using ultrahigh-field MRI. NMR Biomed 26:9-19
Raz, E; Bester, M; Sigmund, E E et al. (2013) A better characterization of spinal cord damage in multiple sclerosis: a diffusional kurtosis imaging study. AJNR Am J Neuroradiol 34:1846-52
Bester, Maxim; Lazar, Mariana; Petracca, Maria et al. (2013) Tract-specific white matter correlates of fatigue and cognitive impairment in benign multiple sclerosis. J Neurol Sci 330:61-6
Grossman, E J; Jensen, J H; Babb, J S et al. (2013) Cognitive impairment in mild traumatic brain injury: a longitudinal diffusional kurtosis and perfusion imaging study. AJNR Am J Neuroradiol 34:951-7, S1-3
Howard, Jonathan; Battaglini, Marco; Babb, James Scott et al. (2012) MRI correlates of disability in African-Americans with multiple sclerosis. PLoS One 7:e43061
Rigotti, D J; Inglese, M; Kirov, I I et al. (2012) Two-year serial whole-brain N-acetyl-L-aspartate in patients with relapsing-remitting multiple sclerosis. Neurology 78:1383-9
Reitz, L Y; Inglese, M; Fiehler, J et al. (2012) Quantitative T2' imaging in patients with clinically isolated syndrome. Acta Neurol Scand 126:357-63
Grossman, Elan J; Ge, Yulin; Jensen, Jens H et al. (2012) Thalamus and cognitive impairment in mild traumatic brain injury: a diffusional kurtosis imaging study. J Neurotrauma 29:2318-27

Showing the most recent 10 out of 33 publications